Neoadjuvant Tislelizumab Plus Chemotherapy for Resectable Locally-advanced Head and Neck Squamous Cell Carcinoma
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Carboplatin
Related studies linked through entity extraction aliases.
A Prospective, Open, Multicenter Single-arm Clinical Studie of Docetaxel, Carboplatin Combined With Inetetamab and Pyrotinib in the Treatment of Local-advanced HER2-positive Breast Cancer
- Status
- RECRUITING
- Phase
- NA
A Trial to Learn How Effective and Safe Odronextamab is Compared to Standard of Care for Adult Participants With Previously Treated Aggressive B-cell Non-Hodgkin Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Neoadjuvant Study of DV in Combination Toripalimab or Sequence Chemotherapy in HR-negative, HER2 Low-expressing Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
A Study of Subcutaneous (SC) Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) vs Intravenous Pembrolizumab in Adult Participants With Metastatic Non-small Cell Lung Cancer (NSCLC) (MK-3475A-D77)-Japan Extension
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study of SHR-A1921 With or Without Carboplatin in Subjects With Ovarian Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2/PHASE3
Phase II Study on Neoadjuvant Therapy of AK104 Combined With Nab-paclitaxel/Carboplatin in Fertility Preserving Surgery
- Status
- RECRUITING
- Phase
- PHASE2
Drug Screening Using IMD in Bladder Cancer
- Status
- ENROLLING_BY_INVITATION
- Phase
- EARLY_PHASE1
A Study of ZL-1310 in Subjects With Small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE1
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
- Status
- RECRUITING
- Phase
- PHASE3
Advanced First-line Treatment of Short-term Postoperative Progression of Head and Neck Squamous Cell Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE2
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Trial to Learn if the Combination of Fianlimab, Cemiplimab, and Chemotherapy is Safe and Works Better Than the Combination of Cemiplimab and Chemotherapy in Adult Patients With Non-Small Cell Lung Cancer That Can be Treated With Surgery
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Beamion LUNG-2: A Study to Test Whether Zongertinib (BI 1810631) Helps People With Advanced Non-small Cell Lung Cancer With HER2 Mutations Compared With Standard Treatment
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Pembrolizumab After Radiation Therapy and Chemotherapy in Limited Stage Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE2
DAREON™-7: A Study to Test How Well Different Doses of BI 764532 in Addition to Chemotherapy Are Tolerated by People With Advanced Neuroendocrine Cancers
- Status
- RECRUITING
- Phase
- PHASE1
BAT1308 Combined with Platinum-Based Chemotherapy± Bevacizumab for PDL1-Positive (CPS ≥1) Cervical Cancer
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
Optimization of Treatment Strategy for Unresectable cN3 Esophageal Squamous Cell Carcinoma
- Status
- RECRUITING
- Phase
- PHASE2
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE3
A Phase III Randomised Study to Evaluate Dato-DXd and Durvalumab for Neoadjuvant/Adjuvant Treatment of Triple-Negative or Hormone Receptor-low/HER2-negative Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3